1.68

3.76% -0.05

Fortress Biotech Inc (FBIO)

Overview News Price History Option Chain Financials Why FBIO Down? Discussions Forecast Stock Split

Fortress Biotech Inc stock is traded at $1.68, with a volume of 984.35K. It is down -3.76% in the last 24 hours and up +2.15% over the past month. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Previous Close:

$1.73

Open:

$1.7

24h Volume:

984.35K

Relative Volume:

1.78

Market Cap:

$46.86M

Revenue:

$80.97M

Net Income/Loss:

$-78.31M

P/E Ratio:

-0.1131

EPS:

-14.85

Net Cash Flow:

$-129.56M

1W Performance:

-17.57%

1M Performance:

+2.15%

6M Performance:

-4.86%

1Y Performance:

-25.67%

1-Day Range:

$1.55

$1.74

1-Week Range:

$1.55

$2.07

52-Week Range:

$1.24

$4.43

Fortress Biotech Inc Stock (FBIO) Company Profile

Name

Fortress Biotech Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

781-652-4500

Address

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Employee

186

Twitter

@fortressbio

Next Earnings Date

2024-11-12

Latest SEC Filings

FBIO's Discussions on Twitter

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-15-24	Resumed	ROTH MKM	Buy
Aug-04-22	Initiated	Ladenburg Thalmann	Buy
Oct-02-20	Initiated	The Benchmark Company	Buy
Dec-18-19	Initiated	B. Riley FBR	Buy
Feb-28-18	Initiated	B. Riley FBR, Inc.	Buy
Jul-11-17	Initiated	Rodman & Renshaw	Buy
Mar-22-17	Initiated	JMP Securities	Mkt Outperform
Oct-03-16	Initiated	ROTH Capital	Buy

View All

Fortress Biotech Inc Stock (FBIO) Latest News

Nov 01, 2024

Fortress Biotech, Inc.'s (NASDAQ:FBIO) Shares Bounce 36% But Its Business Still Trails The Industry - Simply Wall St

Oct 29, 2024

Oct 25, 2024

Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares - Yahoo Finance

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of Fortres - GuruFocus.com

Oct 25, 2024

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - GlobeNewswire

Oct 25, 2024

Mustang Bio secures $4 million from warrant exercises - Investing.com India

Oct 25, 2024

Oct 24, 2024

Mustang Bio secures $4 million from warrant exercises By Investing.com - Investing.com South Africa

Oct 24, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - The Manila Times

Oct 24, 2024

Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - The Manila Times

Oct 09, 2024

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit - GlobeNewswire

Oct 09, 2024

Oct 07, 2024

Analysts review Fortress Biotech Inc’s rating - Knox Daily

Oct 07, 2024

Was there any good news for Fortress Biotech Inc (FBIO) stock in the last session? - US Post News

Oct 07, 2024

Oct 03, 2024

PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD acquire 763,359 shares of Fortress Biotech Inc [FBIO] - Knox Daily

Oct 03, 2024

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire

Oct 03, 2024

Oct 02, 2024